Skip to content

MILESTONE SCIENTIFIC INC.: 10-Q filed 2025-11-13

What MILESTONE SCIENTIFIC INC. reported in its quarterly report filed 2025-11-13 (fiscal Q3 2025): 35 published measures, 104 facts as tagged in accession 0001493152-25-022276.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-13
Fiscal period
fiscal Q3 2025
Accession
0001493152-25-022276 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MILESTONE SCIENTIFIC INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-308,486,023USD
At 2024-12-319,797,072USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-305,936,628USD
At 2024-12-313,964,372USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-302,549,395USD
At 2025-06-303,340,272USD
At 2025-03-314,462,452USD
At 2024-12-315,832,700USD
At 2024-09-307,221,484USD
At 2024-06-307,953,877USD
At 2024-03-317,460,409USD
At 2023-12-318,012,512USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-301,345,301USD
At 2024-12-313,258,058USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1,153,959USD92
2025-01-01 to 2025-09-30-4,631,655USD273
2025-04-01 to 2025-06-30-1,483,110USD91
2025-01-01 to 2025-03-31-1,994,586USD90
2024-07-01 to 2024-09-30-1,461,171USD92
2024-01-01 to 2024-09-30-2,678,062USD274
2024-04-01 to 2024-06-30223,638USD91
2024-01-01 to 2024-03-31-1,440,529USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-2,690,498USD273
2024-01-01 to 2024-09-30-1,408,387USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-09-3012,008USD273
2024-01-01 to 2024-09-306,596USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-30789,749USD273
2024-01-01 to 2024-09-30236,294USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-12,008USD273
2024-01-01 to 2024-09-302,969,977USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-132,684,761USD
At 2024-12-31-128,053,106USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-3082,322,910shares92
2025-01-01 to 2025-09-3082,008,336shares273
2024-07-01 to 2024-09-3079,966,833shares92
2024-01-01 to 2024-09-3080,165,181shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-3082,322,910shares92
2025-01-01 to 2025-09-3082,008,336shares273
2024-07-01 to 2024-09-3079,966,833shares92
2024-01-01 to 2024-09-3080,165,181shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.01USD/shares92
2025-01-01 to 2025-09-30-0.06USD/shares273
2024-07-01 to 2024-09-30-0.02USD/shares92
2024-01-01 to 2024-09-30-0.03USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.01USD/shares92
2025-01-01 to 2025-09-30-0.06USD/shares273
2024-07-01 to 2024-09-30-0.02USD/shares92
2024-01-01 to 2024-09-30-0.03USD/shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-3018,254USD
At 2024-12-3112,921USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-09-30853,548USD273
2024-01-01 to 2024-09-301,005,273USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1,134,471USD92
2025-01-01 to 2025-09-30-4,616,955USD273
2024-07-01 to 2024-09-30-1,469,179USD92
2024-01-01 to 2024-09-30-4,714,670USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-308,110,101USD
At 2024-12-319,286,554USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-305,033,531USD
At 2024-12-313,744,127USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,775,341USD92
2025-01-01 to 2025-09-309,522,866USD273
2024-07-01 to 2024-09-303,305,399USD92
2024-01-01 to 2024-09-309,638,196USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-304,126,988USD
At 2024-12-313,713,215USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,640,870USD92
2025-01-01 to 2025-09-304,905,911USD273
2024-07-01 to 2024-09-301,836,220USD92
2024-01-01 to 2024-09-304,923,526USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,739,011USD92
2025-01-01 to 2025-09-309,026,691USD273
2024-07-01 to 2024-09-303,064,769USD92
2024-01-01 to 2024-09-308,968,226USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-07-01 to 2025-09-3016,226USD92
2025-01-01 to 2025-09-30437,135USD273
2024-07-01 to 2024-09-30232,056USD92
2024-01-01 to 2024-09-30641,235USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-3078,559,147shares
At 2024-12-3178,014,465shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-30178,251USD
At 2024-12-31257,842USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2025-09-3096,039USD
At 2024-12-31148,404USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-09-3024,150USD
At 2024-12-3124,150USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-09-30506,574USD
At 2024-12-31564,645USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1,153,959USD92
2025-01-01 to 2025-09-30-4,631,655USD273
2024-07-01 to 2024-09-30-1,461,171USD92
2024-01-01 to 2024-09-30-2,678,062USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-01-01 to 2025-09-306,675USD273
2024-01-01 to 2024-09-305,355USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-01-01 to 2025-09-3052,365USD273
2024-01-01 to 2024-09-3023,380USD274

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2025-07-01 to 2025-09-3031,882USD92
2025-01-01 to 2025-09-3095,645USD273
2024-07-01 to 2024-09-3030,373USD92
2024-01-01 to 2024-09-3095,645USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30240,073USD273
2024-01-01 to 2024-09-30238,305USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30413,773USD273
2024-01-01 to 2024-09-301,073,450USD274

Inspect the source

Entity
MILESTONE SCIENTIFIC INC. / CIK 0000855683
Captured
2026-09-19T11:14:56.895Z
SEC response SHA-256
362fb0aa83d37d18fac469b6e68835a82a547d733d8af8080ddcc72b4e184c75

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000855683.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))